Showing results (281-290 of 306) with videos related to
Sort By:
Pageof 31
Cancer Immunology, Immunotherapy : CII|July 1, 1993
Clonal analysis of in vivo activated CD8+ cytotoxic T lymphocytes from a melanoma patient responsive to active specific immunotherapyJ Kan-Mitchell, X Q Huang, L Steinman, et al.Neurology|January 26, 2006
Surviving glioblastoma for more than 5 years: the patient's perspectiveJ P Steinbach, H-P Blaicher, U Herrlinger, et al.Science (New York, N.Y.)|April 29, 1988
ADP-ribosyltransferase activity of pertussis toxin and immunomodulation by Bordetella pertussisW J Black, J J Munoz, M G Peacock, et al.Nature Medicine|June 12, 1998
Idiotypic immunization induces immunity to mutated p53 and tumor rejectionP J Ruiz, R Wolkowicz, A Waisman, et al.Controlled Clinical Trials|June 1, 1987
An example of expert systems applied to clinical trials: analysis of serial graded exercise ECG test dataJ M Long, J R Slagle, A S Leon, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 27, 1999
Suppressive immunization with DNA encoding a self-peptide prevents autoimmune disease: modulation of T cell costimulationP J Ruiz, H Garren, I U Ruiz, et al.Nature|March 4, 1993
Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosisJ R Oksenberg, M A Panzara, A B Begovich, et al.The Journal of Experimental Medicine|May 1, 1988
Predominant expression of a T cell receptor V beta gene subfamily in autoimmune encephalomyelitisS S Zamvil, D J Mitchell, N E Lee, et al.Infection|June 27, 2014
Clinical course and quality of care in ART-naïve patients newly presenting in a HIV outpatient clinicM Platten, R Linnemann, T Kümmerle, et al.Genes and Immunity|May 23, 2003
Osteopontin polymorphisms and disease course in multiple sclerosisS Caillier, L F Barcellos, S E Baranzini, et al.Pageof 31